biomarker analysis

Amahealth LLC transforms everyday biometric data from wearable devices into clinical and personal insights supporting individuals and families through fertility, pregnancy, and the postpartum period. Its flagship product, NewDate, applies AI and machine learning to biomarkers such as body temperature and heart rate variability to deliver a personalized 4-day window for likely labor onset.

AI and Machine Learningclinical researchsoftware as a medical device (SaMD)wearable sensor data analysis

DermiSense, Inc. is developing a minimally-invasive, bio-inert organic composite microneedle patch that extracts dermal interstitial fluid (ISF) for local analysis or rapid lab tests, aiming to replace conventional blood draws with a more accessible, painless, and efficient method. The technology can access 93% of the same proteins found in blood plasma and serum and is focused on periodic testing of biomarkers such as cortisol rather than continuous monitoring.

dermal interstitial fluid extractiondiagnostic testing

Filos Health Laboratory is a physician-led, CLIA & COLA accredited clinical laboratory based in Dallas Fort Worth, Texas. It provides precision diagnostics including routine testing, genetic panels, infectious disease diagnostics, drug screening, and occupational health services, with mobile phlebotomy and at-home blood collection across Texas and California.

at-home blood collectionclinical laboratory testingdrug testinggenetic testingmobile phlebotomyonsite employee testingphysician-led diagnostic oversight

Guosa Life Sciences is an integrated clinical development enterprise and the Network Coordinating Center of the Clinical Development Network. It helps sponsors, biotechnology companies, governments, academic institutions and global health organizations accelerate development of innovative medicines through four integrated platforms: GLS Institute, GLS Academy, the Clinical Development Network and Solutions. It operates across the US, Sub-Saharan Africa, Asia, Europe and MENA, with 35+ countries of reach and 60+ research-ready sites.

biospecimen managementCapacity developmentclinical developmentcold chain logisticsGCP audits and inspection readinessIMP distributionPharmacovigilanceregulatory strategy and submissionsstatistical analysis

Inotiv is a contract research organization (CRO) providing nonclinical and analytical drug discovery and development services, research models, and related products and services to pharmaceutical and biotech companies, government, academia, and other life science organizations. Its offerings span discovery through clinical development, including safety assessment, toxicology, DMPK, bioanalysis, histology and pathology, and research model services.

bioanalysiscarcinogenicity studiescontract breedingCRISPR-Cas9 gene editingcustom antibody productiondevelopmental and reproductive toxicologyDMPKgenetically engineered modelsgenetic toxicologyhistologyimmunohistochemistryin situ hybridizationmass spectrometry assayspathologyquantitative image analysissafety pharmacologystereologytoxicology studieswhole slide imaging